K2 Principal Fund, L.P. Senseonics Holdings, Inc. Transaction History

K2 Principal Fund, L.P.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2018 Nov 13, 2018	SELL	$3.4 - $4.84 $699,223 - $995,365	-205,654 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$3.03 - $4.98 $623,131 - $1.02 Million	205,654 New	205,654 $845,000

142

59.9M

393K

254K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $275M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of K2 Principal Fund, L.P., based on Form 13F filings with the SEC.

Stay updated on K2 Principal Fund, L.P. with notifications on news.